Citigroup’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,273
Closed -$10.2K 6090
2025
Q2
$10.2K Buy
+2,273
New +$10.2K ﹤0.01% 5186
2025
Q1
Sell
-1,839
Closed -$11.2K 5596
2024
Q4
$11.2K Buy
+1,839
New +$12.6K ﹤0.01% 5363
2022
Q2
Sell
-35
Closed 6240
2022
Q1
$0 Buy
+35
New +$462 ﹤0.01% 6308

Other funds holding BIOX

Citigroup's BIOX Position: Q3 2025 in Review

Citigroup sold out of Bioceres Crop Solutions (BIOX) in Q3 2025, closing a stake of 2,273 shares — an estimated $10.2K sold.

Citigroup first reported a position in BIOX in Q1 2022 and held it in 3 quarters. The position peaked at $11.2K in Q4 2024. 38 funds tracked by Wall St. Rank hold BIOX as of Q3 2025.

  • Citigroup reported no remaining Bioceres Crop Solutions position as of Q3 2025 after selling out during the quarter.
  • Citigroup sold 2,273 Bioceres Crop Solutions shares in Q3 2025, an estimated $10.2K.
  • Citigroup first reported a position in Bioceres Crop Solutions in Q1 2022 and held it in 3 quarters.
  • Citigroup's Bioceres Crop Solutions position peaked at $11.2K in Q4 2024.
  • 38 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.